EMA Recommends Tepezza for Severe Thyroid Eye Disease

by Medscape • 2025/04/30 • 0 Comments

Teprotumumab is a fully human IgG1 monoclonal antibody that inhibits tissue inflammation and remodeling.
Medscape Medical News

← RevitalVision therapy has potential to improve amblyopia in adults

Azalea Vision sammelt 9 Millionen Euro in erster Finanzierungsrunde der Serie A zur Weiterentwicklung seiner intelligenten vernetzten Bildverarbeitungsplattform →